Jason Barnard
Chief Accounting OfficerMr. Jason Barnard is Chief Accounting Officer of Nektar Therapeutics from January 2025. In this role, he leads the company’s accounting organization and is responsible for the company’s SEC reporting and maintaining its internal control environment. Mr. Barnard has over 18 years of professional experience and has held positions of increasing responsibility at Nektar since joining in 2016, including serving as the company’s Corporate Controller since 2020. Prior to joining Nektar, Mr. Barnard worked at Blackhawk Network where he established the SEC reporting and technical accounting function, from Blackhawk’s IPO through its first SEC filings and multiple business acquisitions. Mr. Barnard is a Certified Public Accountant (Inactive). He received his M.S. in Accountancy from Golden Gate University and his B.A. in Linguistics and Classical Languages from UC Berkeley.
Positions
- Company NameNektar TherapeuticsStock CodeNKTRPositionChief Accounting OfficerColleagues
- HWHoward W. RobinCEO, President & Director
- RBRobert B. ChessIndependent Chairman of the Board
- JZJonathan ZalevskySenior VP and Chief Research & Development Officer
- LMLinda M. RubinsteinCFO and Principal Financial & Accounting Officer
- EZElizabeth ZhangVP of Legal, Corporate Counsel & Secretary
- RARoy A. WhitfieldLead Independent Director
- RSR. Scott GreerIndependent Director
- DMDiana M. BrainardIndependent Director
